BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21867767)

  • 41. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Reactive Oxygen and Nitrogen Species in the Expression and Splicing of Nitric Oxide Receptor.
    Sharina IG; Martin E
    Antioxid Redox Signal; 2017 Jan; 26(3):122-136. PubMed ID: 26972233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
    Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
    J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
    Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of nitric oxide and soluble guanylyl cyclase.
    Krumenacker JS; Hanafy KA; Murad F
    Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
    Rothkegel C; Schmidt PM; Atkins DJ; Hoffmann LS; Schmidt HH; Schröder H; Stasch JP
    Mol Pharmacol; 2007 Nov; 72(5):1181-90. PubMed ID: 17715400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance.
    Sayed N; Kim DD; Fioramonti X; Iwahashi T; Durán WN; Beuve A
    Circ Res; 2008 Sep; 103(6):606-14. PubMed ID: 18669924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
    Filippov G; Bloch DB; Bloch KD
    J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nitric oxide-sensitive guanylyl cyclase is differentially regulated by nuclear and non-nuclear estrogen pathways in anterior pituitary gland.
    Cabilla JP; Nudler SI; Ronchetti SA; Quinteros FA; Lasaga M; Duvilanski BH
    PLoS One; 2011; 6(12):e29402. PubMed ID: 22216273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights into the role of soluble guanylate cyclase in blood pressure regulation.
    Buys E; Sips P
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):135-42. PubMed ID: 24419369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M; Chrapusta SJ; Lukačova N; Langfort J
    Brain Res; 2015 Aug; 1618():29-40. PubMed ID: 26006108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K; Murad F
    Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of sGC-dependent NO signalling and myocardial infarction risk.
    Wobst J; Kessler T; Dang TA; Erdmann J; Schunkert H
    J Mol Med (Berl); 2015 Apr; 93(4):383-94. PubMed ID: 25733135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
    Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
    PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble guanylate cyclase: a potential therapeutic target for heart failure.
    Gheorghiade M; Marti CN; Sabbah HN; Roessig L; Greene SJ; Böhm M; Burnett JC; Campia U; Cleland JG; Collins SP; Fonarow GC; Levy PD; Metra M; Pitt B; Ponikowski P; Sato N; Voors AA; Stasch JP; Butler J;
    Heart Fail Rev; 2013 Mar; 18(2):123-34. PubMed ID: 22622468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line.
    Sharina IG; Martin E; Thomas A; Uray KL; Murad F
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11523-8. PubMed ID: 14504408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The chemistry and biology of soluble guanylate cyclase stimulators and activators.
    Follmann M; Griebenow N; Hahn MG; Hartung I; Mais FJ; Mittendorf J; Schäfer M; Schirok H; Stasch JP; Stoll F; Straub A
    Angew Chem Int Ed Engl; 2013 Sep; 52(36):9442-62. PubMed ID: 23963798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.
    Xu X; Wang S; Liu J; Dou D; Liu L; Chen Z; Ye L; Liu H; He Q; Raj JU; Gao Y
    J Cell Sci; 2012 Dec; 125(Pt 24):6117-26. PubMed ID: 23038777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional significance of hsp90 complexes with NOS and sGC in endothelial cells.
    Antonova G; Lichtenbeld H; Xia T; Chatterjee A; Dimitropoulou C; Catravas JD
    Clin Hemorheol Microcirc; 2007; 37(1-2):19-35. PubMed ID: 17641392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.